WDC
47
4
HAS
33
3
VFC
53
5
KHC
24
13
MA
64
7
ILMN
42
5
NTAP
67
-3
MAS
58
2
MTB
67
2
DTE
56
2
CF
57
-2
EOG
58
2
NWS
66
-3
SEE
56
6
RIG
60
2
MCD
52
2
CL
58
2
HOG
35
2
CMA
61
5
NDAQ
62
2
WDC
47
4
HAS
33
3
VFC
53
5
KHC
24
13
MA
64
7
ILMN
42
5
NTAP
67
-3
MAS
58
2
MTB
67
2
DTE
56
2
CF
57
-2
EOG
58
2
NWS
66
-3
SEE
56
6
RIG
60
2
MCD
52
2
CL
58
2
HOG
35
2
CMA
61
5
NDAQ
62
2
Financhill
Back

Intellia Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison

Sell
23

NTLA
Intellia Therapeutics

Last Price:
14.30
Seasonality Move:
5.23%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Sell
23
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy, Sell or Hold?

  • The current Intellia Therapeutics [NTLA] share price is $14.30. The Score for NTLA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NTLA Stock Price Chart

What is Intellia Therapeutics's stock price today?

  • The Intellia Therapeutics share price today is $14.30
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.14 Sell
Relative Strength Index (14 RSI): 39.75 Sell
Chaikin Money Flow: 970552 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.83 - 17.89) Sell
Bollinger Bands (100): (17.02 - 24.4) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.34 Sell
20-day SMA: 15.15 Sell
50-day SMA: 17.99 Sell
200-day SMA: 23.08 Sell
8-day EMA: 14.4 Sell
20-day EMA: 15.43 Sell
50-day EMA: 17.49 Sell
200-day EMA: 22.86 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

Intellia Therapeutics Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.19 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Intellia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):